The janus face of Bartonella quintana recognition by toll-like receptors (TLRs): A review

European Cytokine Network

Volumn 19, Issue 3, 2008, Pages 113-118

  Matera, Giovanni ^a   Liberto, Maria Carla ^a   Joosten, Leo A B ^b   Vinci, Maria ^a   Quirino, Angela ^a   Pulicari, Maria Concetta ^a   Kullberg, Bart Jan ^b   Van Der Meer, Jos W M ^b   Netea, Mihai G ^b   Focà, Alfredo ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B. Quintana LPS; Cytokine; TLR4

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; CYTOKINE; TOLL LIKE RECEPTOR;

ANTIGEN RECOGNITION; BARTONELLA QUINTANA; CHO CELL; CYTOKINE PRODUCTION; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXTRACTION; GENETIC TRANSFECTION; HOST RESISTANCE; HUMAN; IMMUNOSTIMULATION; MONONUCLEAR CELL; NONHUMAN; PURIFICATION; REVIEW; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; TRENCH FEVER;

BACTERIA (MICROORGANISMS); BARTONELLA QUINTANA; MUS;

ANIMALS; BARTONELLA QUINTANA; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPOPOLYSACCHARIDES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TRENCH FEVER;

EID: 58149399288     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2008.0128     Document Type: Review

References (36)

1. Dehio C. Molecular and cellular basis of Bartonella pathogenesis. Annu Rev Microbiol 2004; 58: 365.
2. Bruneel F, D'Estanque J, Fournier PE, et al. Isolated right-sided Bartonella quintana endocarditis in an immunocompetent adult. Scand J Infect Dis 1998; 30: 24.
3. Anderson BE, Neuman MA. Bartonella spp. as emerging human pathogens. Clin Microbiol Rev 1997; 10: 203.
4. Brouqui P, Lascola B, Roux V, et al. Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med 1999; 340: 184.
5. Maurin M, Raoult D. Bartonella (Rochalimaea) quintana infections. Clin Microbiol Rev 1996; 9: 273.
6. Raoult D, Fournier PE, Drancourt M, et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 1996; 125: 646.
7. Capo C, Amirayan-Chevillard N, Brouqui P, et al. Bartonella quintana bacteremia and overproduction of interleukin-10: model of bacterial persistence in homeless people. J Infect Dis 2003; 187: 837.
8. Munford RS, Varley AW. Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria. PLoS Pathog 2006; 2: e67.
9. Poltorak A, He X, Smirnova I, Liu MY, et al. Defective LPS signalling in C3H/HeJ and C57Bl/10ScCr mice: mutations in TLR4 gene. Science 1998; 282: 2085.
10. Rietschel ET, Brade H, Brade L, et al. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. In: Sturk A, van Deventer SJ, eds. Detection ofbacterial endotoxins with the Limulus Amebocyte Lysate test. New York: Alan R. Liss, Inc., 1987: 25-53.
11. Zahringer U, Lindner B, Knirel YA, et al. Structure and biological activity of the short-chain lipopolysaccharide from Bartonella- henselae ATCC 49882T. J Biol Chem 2004; 279: 21046.
12. Matera G, Liberto MC, Quirino A, et al. Bartonella quintana li- popolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood and a rat model. Int Immunopharmacol 2003; 3: 853.
13. Liberto MC, Matera G. Pathogenic mechanisms of Bartonella quintana. New Microbiol 2000; 23: 449.
14. Liberto MC, Matera G, Lamberti AG, et al. In vitro Bartonella quintana infection modulates the programmed cell death and inflammatory reaction of endothelial cells. Diag Microbiol Infect Dis 2003; 45: 107.
15. Montminy SW, Khan N, McGarth S, et al. Virulence factors of Yersinia pestis are overcome by strong lipopolysaccharide response. Nat Immunol 2006; 7: 1066.
16. McCord AM, Burgess AW, Whaley MJ, et al. Interaction of Bar- tonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration. Infect Immun 2005; 73: 5735.
17. Vermi W, Facchetti F, Riboldi E, et al. Role of dendritic cell- derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma. Blood 2006; 07: 454.
18. Fuhrmann O, Arvand M, Gohler A, et al. Bartonella henselae induces NF-kappa B-dependent upregulation of adhesion molecules in cultured human endothelial cells: possible role of outer membrane proteins as pathogenic factors. Infect Immun 2001; 69: 5088.
19. Riess T, Andersson SG, Lupas A, et al. Bartonella adhesin A mediates a proangiogenic host cell response. J Exp Med 2004; 200: 1267.
20. Agrawal S, Agrawal A, Doughty B, et al. DifferentToll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos. J Immunol 2003; 171: 4984.
21. Netea MG, Sutmuller R, Hermann C, et al. Toll-like receptor 2 inhibits cellular responses against Candida albicans through pathways mediated by IL-10 and CD4+CD25+ regulatory T cells. J Immunol 2004; 172: 3712.
22. Dillon S, Agrawal A, Van Dycke T, et al. Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen activated protein kinase and c-Fos in dendritic cells. J Immunol 2004; 172: 4733.
23. Sutmuller RP, den Brok MH, Kramer M, et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. JClin Invest 2001; 116: 1485.
24. Andersen-Nissen E, Smith KD, Strobe KL, et al. Evasion of Tolllike receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 2005; 102: 9247.
25. Lepper PM, Triantafilou M, Schumann C, et al. Lipopolysaccha- rides from Helicobacter pylori can act as antagonists for Toll-like receptor 4. Cell Microbiol 2005; 7: 519.
26. Netea MG, van Deuren M, Kullberg BJ, et al. Does the shape of lipid A determine the interaction of lipopolysaccharides with Tolllike receptors? Trends Immunol 2002; 23: 135.
27. Yoshimura A, Kaneko T, Kato Y, et al. Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capno- cytophaga ochracea are antagonists for human toll-like receptor 4. Infect Immun 2002; 70: 218.
28. Heine H, Kirschning CJ, Lien E, et al. Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J Immunol 1999; 162: 6971.
29. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335.
30. Hirschfeld M, Weis JJ, Toshchakov V, et al. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 2001; 69: 1477.
31. Manthey CL, Vogel SN. Elimination of trace endotoxin protein from rough chemotype LPS. J Endotoxin Res 1994; 1: 84.
32. Popa C, Abdollahi-Roodsaz S, Joosten LA, et al. Bartonella quin- tana lipopolysaccharide is a natural antagonist ofToll-like receptor 4. Infect Immun 2007; 75: 4831.
33. Macagno A, Molteni M, Rinaldi A, et al. A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. J Exp Med 2006; 203: 1481.
34. Schromm AB, Brandenburg K, Loppnow H, et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem 2000; 267: 2008.
35. Brentano F, Kyburz D, Schorr O, et al. The role ofToll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol 2005; 233: 90.
36. Abdollahi-Roodsaz S, Joosten LAB, Roelofs MF, et al. Inhibition of TLR4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 2007; 56: 2957.